Laxxon Medical

Laxxon Medical is at the forefront of pharmaceutical innovation with a focus on 3D screen printing technology that transforms drug formulation and delivery.The company`s proprietary SPID®-Technology is setting new standards in oral medication by enabling customizable drug release profiles and improved bioavailability.This highly adaptable manufacturing method is applicable to various therapeutic areas, extending patent life for generics and facilitating the development of new drugs. Laxxon has bolstered its intellectual property stance with a U.S. patent for the sequential release of multiple drugs within a single dosage form.Collaborations, such as with Adare Pharma Solutions, leverage cGMP facilities in Europe and the U.S.,ensuring both clinical and commercial production of these advanced drug delivery systems. By enhancing bioavailability up to 10-fold against existing alternatives,Laxxon`s offerings present a significant leap forward in pharmaceutical efficacy and patient outcomes.